TransCode Therapeutics, Tonix Pharmaceuticals, GeoVax Labs, BioCorRx Inc., Lifespring Chiropractic, Silicon Valley Hair Institute, Collaborative Bridges, and Ourian Plastic Surgery announce significant updates in the biotech, healthcare, and wellness sectors.

HeartBeam to discuss software clearance at JP Morgan Conference; Telomir Pharmaceuticals reports positive results for Telomir-1 in breast cancer study.

Kemal Erkan reaches 200k YouTube subscribers, Ethema Health terminates partnership, Nutriband Inc. CEO shares achievements and outlook, Profound Medical Corp. closes $36M offering.

Kemal Erkan celebrates YouTube milestone, Ethema Health ends partnership, Nutriband and Profound Medical share company updates.

Lionheart Health, Inc. has developed a bioelectric stimulation platform to improve peptide uptake and effectiveness in various delivery methods. This innovation targets healthspan pathways, enhancing absorption and signaling efficiency for peptides like klotho and sirtuins. Early data suggests a significant increase in efficacy, potentially allowing for lower doses with the same impact, positioning Lionheart Health as a leader in optimizing peptide and protein activity.

Lexaria Bioscience Corp. showcases the potential benefits of its DehydraTECH platform technology in a Phase 1b study, while Wellness Eternal highlights the top verified wellness and longevity companies. Additionally, Freedom at The Mat introduces an AI-generated brand anthem for relaxation, and Med Clinic Authority offers a scalable platform for launching modern telehealth clinics.

Tonix Pharmaceuticals Holding Corp. provided updates on TNX-4800, a long-acting antibody for Lyme disease prophylaxis, while also announcing a $20 million offering for product development. Nutriband Inc. sold a majority stake in Pocono Pharmaceutical to fund the development of an abuse-deterrent fentanyl patch. Additionally, experts are exploring the impact of screen time and lifestyle on pediatric brain tumors, with companies like CNS Pharmaceuticals Inc. working on new therapeutics.

Branded Legacy, Inc. (OTC: BLEG) eliminates $1 million in legacy debt to improve financial flexibility under new leadership, while NavioMD launches a telehealth platform emphasizing clinician-guided care and responsible telehealth practices, aiming to meet the increasing demand for accessible healthcare solutions.

The Personalised Pain Reset Planner by Analgesia is a new digital tool in the UK designed to help individuals with chronic back and nerve pain manage their symptoms by tracking, understanding, and managing pain patterns. By combining structured pain tracking with an Anti-Inflammatory Lifestyle Blueprint, users gain clarity and insight into how movement, sleep, stress, and daily habits interact with their pain. This planner, available online from December 29, 2025, provides a self-management approach for personalized and sustainable solutions for chronic pain.

The progress in Radionuclide Drug Conjugates (RDCs) research for cancer management is highlighted, showcasing precision tumor targeting and personalized therapy. Prof. Hongyun Wang emphasizes RDCs' potential for accurate diagnoses and effective treatment. Meanwhile, Avantor, Inc. appoints Gladys Wang as Vice President for Bioprocessing Commercial in Asia, Middle East, and Africa, aiming to drive business expansion and enhance customer success in the region.

Ace Therapeutics introduces a comprehensive schizophrenia animal model R&D platform to accelerate drug discovery, offering customizable projects and end-to-end support. Meanwhile, Radixweb's 2026 Global AI in Healthcare Report reveals a need for more training among healthcare professionals to effectively utilize AI, highlighting a skill gap and challenges in system integration and value realization. The future of AI in healthcare relies on workforce skills, interoperable infrastructure, and governance models for clinical trust and operational growth.

Welcome to America Magazine features Dr. Anna Chacón, a board-certified dermatologist and inspiring female leader in medicine and business. Her story of democratizing access to dermatological care and commitment to excellence serves as a role model for aspiring health professionals. In other news, BioCorRx Inc. provides an update on its OTC Markets quotation status and upcoming Form S1 filing, emphasizing no impact on business operations or SEC reporting.

Gelbmann Podiatry emphasizes patient-focused care for early diagnosis and treatment of foot conditions to prevent long-term mobility issues. Meanwhile, a new self-healing transparent coating developed by a collaboration of universities repairs scratches and fights bacteria, offering a promising solution for protecting various surfaces from wear and microbial contamination.

Taylor Swift has generously donated $1 million to the American Heart Association to support research, prevention efforts, and access to life-saving care in honor of her father. This contribution will help improve heart health and save lives by raising awareness about cardiovascular disease. Additionally, researchers are exploring new approaches to increase response rates for cancer immunotherapy through startups like Valora Therapeutics and companies like Calidi Biotherapeutics Inc., with support from platforms like BioMedWire.

HealthLynked Corp. partners with PBACO Holding LLC to enhance its integration with insurance payers, Quantum BioPharma advances towards clinical trials for Lucid-MS in multiple sclerosis treatment, Dentistry of Oxnard offers comprehensive dental services, and Oncotelic Therapeutics introduces a breakthrough Nanomedicine Platform for drug delivery in oncology and immunology.

Dr. Richard Ruhling discusses the dangers of pharmaceutical treatments, advocating for healthy habits over drugs based on his experience at Loma Linda University. His book 'Health Happiness and Destiny' offers valuable insights for those seeking a natural approach to healthcare.

DiNAQOR AG strengthens its leadership team with key appointments, focusing on creating and scaling next-generation biotechnology ventures. Soligenix Inc. reports positive results from its SGX302 clinical trial for psoriasis treatment, showcasing clinical improvements with an optimized gel formulation. Additionally, researchers have developed a new blood test to assess the effectiveness of brain cancer treatments, potentially revolutionizing treatment decisions for patients.

Prominent individuals have been appointed to the boards of TransCode Therapeutics, Oncotelic Therapeutics, and NeuroOne Medical Technologies to drive advancements in RNA therapeutics, AI-driven biotechnology, and neurological disorder treatment. Additionally, a specialized center, UroLux Concierge™, is launching to provide tailored care for menopausal women, while ALIGN Integrated Health successfully helped a diabetic patient avoid foot amputation through early intervention and coordinated care.

ADAP Advocacy's '340B Too Big to Fail – Charity Care' infographic highlights the diminishing charity care provided by hospitals, leading to over $220 billion in patient medical debt, disproportionately affecting Black and Hispanic communities. Meanwhile, Creative Biolabs has expanded its iPSC services to support neuroscience research, offering comprehensive characterization packages and CRISPR-Cas9 editing capabilities for studying human biology and neurological disorders with precision.

HeartBeam is a Global IP and Technology Leader in Portable Cardiac Diagnostics, specializing in 12-lead ECG innovation. Meanwhile, a study reveals chronic inflammation as a key driver of long Covid, prompting further research and investment in addressing this issue by companies like Soligenix Inc.